Additionally, caffeine reduced CD68 and IBA-1, markers associated with microglia activation in the hippocampus, and decreased inflammatory markers, including nitric oxide (NO), IL-1, TNF-alpha, and NFkB [39]
While results may differ between individuals, most people begin to see weight loss within the first few weeks of starting GLP-1 therapy
And if semaglutide alone does not deliver the desired results, alternatives like tirzepatide represent the next step in GLP-1 therapy
While GLP-1 and GIP receptor activation primarily reduce energy intake through appetite suppression and delayed gastric emptying, glucagon receptor activation continues to drive energy expenditure through thermogenesis and hepatic fat oxidation regardless of whether caloric intake has already decreased
Its very exciting because I've been able to help a lot of people